Tony Dung Ling Yao

FDMT

DIRECTOR · 4D MOLECULAR THERAPEUTICS, INC. · CIK 0001771680

FILING MIX · LIFETIME57%/43%

BUYS

SELLS

TOTAL VALUE

$9.78M

COMPANIES

ACTIVE SINCE

Dec 2020

HOLDINGS NOW

AVG SELL PX

—

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

1 backtested trades · 8 horizonsHow are these numbers computed? →

Forward-return performance of every backtestable P/S trade by Tony Dung Ling Yao, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.

HORIZON	TRADES	WIN RATE	INSIDER RETURN	SPY RETURN	MEAN EXCESS	MEDIAN EXCESS	T-STAT
7d	1	+100.00%	+2.73%	-0.22%	+2.95%	+2.95%	—
14d	1	+100.00%	+4.27%	+0.94%	+3.34%	+3.34%	—
30d	1	+100.00%	+16.31%	+2.84%	+13.47%	+13.47%	—
60d	1	+100.00%	+13.55%	+6.69%	+6.86%	+6.86%	—
90d	1	+100.00%	+24.05%	+7.71%	+16.33%	+16.33%	—
180d	1	+0.00%	-25.99%	+15.93%	-41.92%	-41.92%	—
1y	1	+0.00%	-47.51%	+29.13%	-76.64%	-76.64%	—
2y	1	+0.00%	-41.62%	+8.53%	-50.15%	-50.15%	—

How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.

Holdings over time

FDMT · 0 shares · as of Dec 15, 2020

Trading cadence · quarterly flow

BUY ● SELL ●

2020

FLOW · 4 buys / 3 sellsCOVERAGE · 1 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
FDMT 4D MOLECULAR THERAPEUTICS, INC.	SALE	455,326	—	—	0	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	PURCHASE	425,000	$23.00	$9.78M	1,060,880	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	SALE	2,864	—	—	0	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	PURCHASE	455,326	—	—	455,326	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	PURCHASE	2,864	—	—	2,864	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	PURCHASE	180,554	—	—	635,880	Dec 15, 2020	Dec 17, 2020 ↗	View →
FDMT 4D MOLECULAR THERAPEUTICS, INC.	SALE	180,554	—	—	0	Dec 15, 2020	Dec 17, 2020 ↗	View →

Other insiders · FDMT

Loading peer insiders…

About this filer

CIK 0001771680

ROLE

Director

PRIMARY

FDMT

COMPANIES

ACTIVE SINCE

Dec 2020

MARKETPEEL · /INSIDER/0001771680DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

Tony Dung Ling Yao

The morning brief, before the bell.